Revvity, Inc. (NYSE:RVTY) Shares Purchased by Vanguard Group Inc.

Vanguard Group Inc. increased its holdings in shares of Revvity, Inc. (NYSE:RVTY - Free Report) by 1.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,290,211 shares of the company's stock after purchasing an additional 156,679 shares during the quarter. Vanguard Group Inc. owned 11.74% of Revvity worth $1,594,930,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of RVTY. Assetmark Inc. boosted its position in shares of Revvity by 3,700.0% during the fourth quarter. Assetmark Inc. now owns 266 shares of the company's stock worth $30,000 after buying an additional 259 shares during the period. Continuum Advisory LLC boosted its holdings in Revvity by 2,972.7% during the 3rd quarter. Continuum Advisory LLC now owns 338 shares of the company's stock valued at $43,000 after acquiring an additional 327 shares during the period. Millstone Evans Group LLC acquired a new position in Revvity in the 4th quarter valued at about $38,000. MassMutual Private Wealth & Trust FSB increased its stake in Revvity by 55.9% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock worth $43,000 after purchasing an additional 138 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Revvity by 33.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock worth $58,000 after purchasing an additional 131 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Analyst Upgrades and Downgrades

RVTY has been the subject of a number of research reports. KeyCorp lifted their price objective on shares of Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Barclays upped their price objective on Revvity from $135.00 to $140.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Bank of America upgraded Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price objective on the stock in a research note on Friday, December 13th. Raymond James reissued an "outperform" rating and set a $145.00 target price (up from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Finally, Sanford C. Bernstein lowered Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target on the stock. in a research report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $136.25.

Remove Ads

Insiders Place Their Bets

In other Revvity news, insider Tajinder S. Vohra sold 5,492 shares of the firm's stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total transaction of $641,520.52. Following the transaction, the insider now directly owns 19,652 shares of the company's stock, valued at approximately $2,295,550.12. This trade represents a 21.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Joel S. Goldberg sold 15,170 shares of Revvity stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the completion of the transaction, the insider now owns 33,400 shares in the company, valued at approximately $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.68% of the company's stock.

Revvity Stock Down 1.5 %

Shares of NYSE RVTY traded down $1.56 during midday trading on Tuesday, hitting $104.24. 980,274 shares of the company's stock were exchanged, compared to its average volume of 876,441. The firm's fifty day simple moving average is $114.52 and its 200-day simple moving average is $116.91. The company has a market cap of $12.52 billion, a PE ratio of 47.17, a P/E/G ratio of 3.82 and a beta of 1.06. Revvity, Inc. has a twelve month low of $97.32 and a twelve month high of $129.50. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, topping analysts' consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter in the previous year, the company earned $1.25 EPS. Research analysts predict that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be paid a $0.07 dividend. The ex-dividend date is Thursday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.27%. Revvity's dividend payout ratio is presently 12.67%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.